Technology for the manufacture and use of chlorine dioxide disinfection preparations, for the control of outbreaks of disease pathogenic micro-organisms with a high resistance to chemical disinfection. (Q78589): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Label in wikidata changed) |
(Created claim: summary (P836): Reference_reference_programme_aids:SA.41471 (2015/X) _public:Article 25 of Commission Regulation (EC) No 651/2014 of 17 June 2014 declaring certain categories of aid compatible with the internal market in the application of Article 107 and 108 of the Treaty (OJ(OJ LEU L 187/1, 26.06.2014).The purpose of the project is to develop the composition and technology of manufacturing and the methods of application of a series of innovative disinfectants...) |
||
| Property / summary | |||
Reference_reference_programme_aids:SA.41471 (2015/X) _public:Article 25 of Commission Regulation (EC) No 651/2014 of 17 June 2014 declaring certain categories of aid compatible with the internal market in the application of Article 107 and 108 of the Treaty (OJ(OJ LEU L 187/1, 26.06.2014).The purpose of the project is to develop the composition and technology of manufacturing and the methods of application of a series of innovative disinfectants and anti-chlorinated disinfectants, to be used in medical areas.The aim of the work will be to obtain new biocidal products with effectiveness:bactericidal, slimicides, and spore, including combating Clostridium difficile forms of spore bacteria, as the most resistant pathogenic pathogen, which is a dominant epidemic outbreak in therapeutic facilities.The new approach will also be to evaluate the efficacy of biocidal product products by means of authorised support tests on the basis of the most recent draft European standards.The application of the carrier standards is the most faithful to that of the conditions for the disinfection of the area to be disinfected.The resulting concentrations of effective biocidal products are more than a dozen or several times higher than those previously established.As a result, the parameters of the operation of disinfection preparations designated by the suspension methods do not confirm their effectiveness in practice, given that the test suspension of the micro-organism undergoes an excessive chemical volume of the disinfectant as compared to the actual conditions.The value methods used to date should not be recommended for use in therapeutic facilities.A new feature will also be a clinical trial showing evidence that the use of the disinfectants in question will have an impact on the decrease in the maturity of the minor concerned. (English) | |||
| Property / summary: Reference_reference_programme_aids:SA.41471 (2015/X) _public:Article 25 of Commission Regulation (EC) No 651/2014 of 17 June 2014 declaring certain categories of aid compatible with the internal market in the application of Article 107 and 108 of the Treaty (OJ(OJ LEU L 187/1, 26.06.2014).The purpose of the project is to develop the composition and technology of manufacturing and the methods of application of a series of innovative disinfectants and anti-chlorinated disinfectants, to be used in medical areas.The aim of the work will be to obtain new biocidal products with effectiveness:bactericidal, slimicides, and spore, including combating Clostridium difficile forms of spore bacteria, as the most resistant pathogenic pathogen, which is a dominant epidemic outbreak in therapeutic facilities.The new approach will also be to evaluate the efficacy of biocidal product products by means of authorised support tests on the basis of the most recent draft European standards.The application of the carrier standards is the most faithful to that of the conditions for the disinfection of the area to be disinfected.The resulting concentrations of effective biocidal products are more than a dozen or several times higher than those previously established.As a result, the parameters of the operation of disinfection preparations designated by the suspension methods do not confirm their effectiveness in practice, given that the test suspension of the micro-organism undergoes an excessive chemical volume of the disinfectant as compared to the actual conditions.The value methods used to date should not be recommended for use in therapeutic facilities.A new feature will also be a clinical trial showing evidence that the use of the disinfectants in question will have an impact on the decrease in the maturity of the minor concerned. (English) / rank | |||
Normal rank | |||
Revision as of 09:29, 4 March 2020
Project in Poland financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Technology for the manufacture and use of chlorine dioxide disinfection preparations, for the control of outbreaks of disease pathogenic micro-organisms with a high resistance to chemical disinfection. |
Project in Poland financed by DG Regio |
Statements
3,427,517.7 zloty
0 references
4,465,137.62 zloty
0 references
76.76 percent
0 references
1 May 2018
0 references
30 April 2023
0 references
MEXEO WIESŁAW HRECZUCH
0 references
50°20'43.8"N, 18°14'41.3"E
0 references
Numer_referencyjny_programu_pomocowego: SA.41471(2015/X) Przeznaczenie_pomocy_publicznej: art. 25 rozporządzenia KE nr 651/2014 z dnia 17 czerwca 2014 r. uznające niektóre rodzaje pomocy za zgodne z rynkiem wewnętrznym w stosowaniu art. 107 i 108 Traktatu (Dz. Urz. UE L 187/1 z 26.06.2014). Przedmiotem projektu jest opracowanie składu i technologii wytwarzania oraz sposobów aplikacji serii innowacyjnych środków dezynfekujących i myjąco-dezynfekujących na bazie ditlenku chloru, do zastosowania w obszarach medycznych. Celem pracy będzie otrzymanie nowych produktów biobójczych o skuteczności: bakteriobójczej, prątkobójczej grzybobójczej, wirusobójczej i sporobójczej, włącznie ze zwalczaniem form przetrwalnikowych bakterii Clostridium difficile, jako najbardziej opornego patogenu, stanowiącego dominujące ogniska epidemiczne w obiektach leczniczych. Nowością będzie także metoda oceny skuteczności biobójczej produktów projektu na drodze autoryzowanych badań nośnikowych w oparciu o najaktualniejsze projekty norm europejskich. Zastosowane normy nośnikowe w sposób najwierniejszy symulują warunki dezynfekowania badanych powierzchni. Otrzymane wartości stężeń skutecznych biobójczo, są kilkanaście lub kilkadziesiąt razy wyższe niż wyznaczone dotychczas praktykowanymi metodami zawiesinowymi. W rezultacie parametry działania preparatów dezynfekcyjnych wyznaczone metodami zawiesinowymi nie potwierdzają ich skuteczności w praktyce, z uwagi na fakt że zawiesina testowych drobnoustrojów poddawana jest nadmiernej objętości chemicznego preparatu dezynfekcyjnego w porównaniu do warunków rzeczywistych. Uzyskane w dotychczas stosowanych metodach wartości stężenia bójczego nie powinny być zalecane do stosowania w obiektach leczniczych. Nowością będą także badania kliniczne pokazujące dowody, że stosowanie przedmiotowych środków dezynfekcyjnych będzie miało wpływ na zmniejszenie zapadalności na C. difficile. (Polish)
0 references
Reference_reference_programme_aids:SA.41471 (2015/X) _public:Article 25 of Commission Regulation (EC) No 651/2014 of 17 June 2014 declaring certain categories of aid compatible with the internal market in the application of Article 107 and 108 of the Treaty (OJ(OJ LEU L 187/1, 26.06.2014).The purpose of the project is to develop the composition and technology of manufacturing and the methods of application of a series of innovative disinfectants and anti-chlorinated disinfectants, to be used in medical areas.The aim of the work will be to obtain new biocidal products with effectiveness:bactericidal, slimicides, and spore, including combating Clostridium difficile forms of spore bacteria, as the most resistant pathogenic pathogen, which is a dominant epidemic outbreak in therapeutic facilities.The new approach will also be to evaluate the efficacy of biocidal product products by means of authorised support tests on the basis of the most recent draft European standards.The application of the carrier standards is the most faithful to that of the conditions for the disinfection of the area to be disinfected.The resulting concentrations of effective biocidal products are more than a dozen or several times higher than those previously established.As a result, the parameters of the operation of disinfection preparations designated by the suspension methods do not confirm their effectiveness in practice, given that the test suspension of the micro-organism undergoes an excessive chemical volume of the disinfectant as compared to the actual conditions.The value methods used to date should not be recommended for use in therapeutic facilities.A new feature will also be a clinical trial showing evidence that the use of the disinfectants in question will have an impact on the decrease in the maturity of the minor concerned. (English)
0 references
Identifiers
POIR.01.01.01-00-1104/17
0 references